Sarah M. Lo, MD, MPH
About Sarah M. Lo, MD, MPH
Titles
Attending Physician
Clinical Assistant Professor, Division of Oncology, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania
Certifications
Pediatric Hematology-Oncology – American Board of Pediatrics
Pediatrics – American Board of Pediatrics
Awards and Honors
2004, Resident Research Award, 1st Place, Children's Hospital at Montefiore, Montefiore Medical Center
2003, Macy Scholarship, Mailman School of Public Health, Columbia University
2001, American Society of Clinical Pathology Award for Academic Excellence and Achievement, Albert Einstein College of Medicine, Yeshiva University
1998, Phi Beta Kappa, Barnard College, Columbia University
1998, Summa Cum Laude, Barnard College, Columbia University
1998, Honors in Political Science, Barnard College, Columbia University
1998, Dean's List, Barnard College, Columbia University
Leadership and Memberships
Memberships in Professional Organizations
2015-present, American Society for Transplantation and Cellular Therapy
2008-present, American Society of Pediatric Hematology-Oncology
2006-present, American Academy of Pediatrics
Education & training
Graduate Degree
MPH - Mailman School of Public Health, Columbia University, New York, NY
Medical Degree
MD - Albert Einstein College of Medicine, Yeshiva University, Bronx, NY
Residency
Pediatrics - Montefiore Medical Center, Children's Hospital at Montefiore, Bronx, NY
Fellowship
Pediatric Hematology Oncology - Yale School of Medicine, Yale University, New Haven, CT
Additional Training
Professional Achievement in Narrative Medicine - School of Professional Studies, Columbia University, New York, NY
Publications
Publications
2013
Shah S, Schrader K, Waanders E, et al.: A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nat Genet 45(10): 1226-31, Oct 2013.
2012
Lo SM, Choi M, Liu J, Jain D, Boot RG, Kallemeijn WW, Aerts JM, Pashankar F, Kupfer GM, Mane S, Lifton RP, Mistry PK: Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematological malignancy phenotype by individual genome analysis. Blood 119(20): 4731-40, May 2012.
2011
Lo SM, Liu J, Chen F, Pastores GM, Knowles J, Boxer M, Aleck K, Mistry PK: Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy. J Inherit Metab Dis 34(3): 643-50, Jun 2011.
2010
Lo SM, Stein P, Mullaly S, Bar M, Jain D, Pastores GM, Mistry PK.: Expanding spectrum of the association between type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types - correlation with genotype and phenotype. Am J Hematol 85(5): 340-5, May 2010.
Lo SM, McNamara J, Seashore MR, Mistry PK.: Misdiagnosis of Niemann-Pick Disease type C as Gaucher Disease: lack of response to macrophage-targeted glucocerebrosidase enzyme replacement therapy. J Inherit Metab Dis Sept 2010.
2006
Sharif I, Lo S, Ozuah PO.: Availability of Spanish prescription labels. J Health Care Poor Underserved 17(1): 65-9, Feb 2006.
Lo S, Sharif I, Ozuah PO: Health literacy among English-speaking parents in a poor urban setting. J Health Care Poor Underserved 17(3): 504-11, Aug 2006.
2005
Zelcer S, Kellick M, Wexler LH, Shi W, Sankaran M, Lo S, Healey J, Huvos AG, Meyers PA, Gorlick R: Methotrexate levels and outcome in osteosarcoma. Pediatric Blood Cancer 44(7): 638-42, Jun 2005.